Explore Baxterhealthcare.co.uk

This site is intended for Healthcare Professionals Only

Renal Care United Kingdom

Therapies

We deliver and support renal therapies across the continuum of care, including the innovative HDx.

  • Peritoneal Dialysis

    Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve end-stage kidney disease patient clinical outcomes and increase lifestyle flexibility.

  • Haemodialysis

    Haemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.

  • HDx

    Innovative Expanded Haemodialysis (HDx) therapy is the next evolution in haemodialysis treatment.

Products

Learn more about Baxter’s key products for Renal Care – across the continuum of care.

Data & Insights

Research enabling innovative renal care and inspirational patient stories

Clinical Data

Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter. 

clinical-data-module-image2.png
Clinical Data – PD •

Remote Patient Management technology enhances the experience of Automated Peritoneal Dialysis

The flexibility that Peritoneal Dialysis (PD) offers renal patients allows them to maintain their lifestyle and independence. When Automated PD is combined with Remote Patient Monitoring, the flexibility is further enhanced and is associated with the potential to improve clinical outcomes and adherence.

Read More

A Focus on Clinical Research

Modern PD

Kidney International: Predictors of the Tate of Decline of Residual Renal Function in Incident Dialysis Patients

View resource
Modern PD

Nephrol Dial Transplant: A Prospective Evaluation of Renal Replacement Therapy Modality Eligibility

View resource
Modern PD

Nephrol Dial Transplant: Engagement in Decision-Making and Patient Satisfaction: A Qualitative Study of Older Patients’ Perceptions of Dialysis Initiation and Modality Decisions

View resource
Modern PD

Nephrol Dial Transplant: Factors associated with Suboptimal Initiation of Dialysis Despite Early Nephrologist Referral

View resource
Modern PD

Nephron: Longitudinal Experience with Remote Monitoring for Automated Peritoneal Dialysis Patients

View resource
Modern PD

Nephron: UK Renal Registry 18th Annual Report: Chapter 11 2014 Multisite Dialysis Access Audit in England, Northern Ireland and Wales and 2013 PD One Year Follow-up: National and Centre-specific Analyses

View resource
Modern PD

Nephron: UK Renal Registry 18th Annual Report: Chapter 11 2014 Multisite Dialysis Access Audit in England, Northern Ireland and Wales and 2013 PD One Year Follow-up: National and Centre-specific Analyses

View resource
Modern PD

Peritoneal Dialysis International: Association of Pre-Transplant Dialysis Modality and Post-Transplant Outcomes: A Meta-Analysis

View resource
Modern PD

Peritoneal Dialysis International: The Benefit of Early Survival on PD Versus HD—Why This Is (Still) Very Important

View resource
Modern PD

Qual Life Res: Quality of Life and Emotional Distress in Patients and Burden in Caregivers: A Comparison Between Assisted Peritoneal Dialysis and Self-Care Peritoneal Dialysis

View resource
Modern PD

Seminars in Dialysis: Changing Landscape for Peritoneal Dialysis: Optimizing Utilization

View resource
Modern PD

The American Society of Nephrology: Effect of an In-Hospital Chronic Kidney Disease Education Program among Patients with Unplanned Urgent-Start Dialysis

View resource

Are you interested in additional information about ways in which we are transforming Renal Care through Patient-Centric Innovations?

Request information here

About Us
Baxter has been a front-runner in the treatment and management of end-stage kidney disease for over 85 years. Today, our state-of-the-art solutions for both haemodialysis  and peritoneal dialysis are transforming global renal care. It’s why you can rely on us to be the type of dedicated partner who understands the challenges you face throughout the continuum of care to meet the individual needs of your patients.

Baxter, AK 98, AN69, Artis Physio Plus, BiCart, CWP 800, Evodial, Homechoice, Nephral ST, Novaline, Polyflux, Revaclear, Sharesource, Sharesource Adequest, SoftPac, SelectBag, Theralite and Theranova are trademarks of Baxter International Inc. or its subsidiaries.

©Copyright 2025 Baxter. All rights reserved.